A Study of Tirzepatide Concentrations at Different Injection Sites in Participants With Different Body Sizes
Status:
Completed
Trial end date:
2020-04-03
Target enrollment:
Participant gender:
Summary
The purpose of this study is to compare the amount of tirzepatide that gets into the blood
stream and how long it takes the body to get rid of it, when injected under the skin of the
upper arm and thigh compared to the abdomen. The study will be conducted in healthy males and
females with different body sizes. The tolerability of tirzepatide will be evaluated and
information about any side effects experienced will be collected. For each participant, the
study will last about 20 weeks, including screening.